Webpackaging logo

New DMF awarded to Coster MDI valves – 20DR & 20DPH

  • Coster
Health, Primary Packaging, Closure Components, Valves, Laboratory, Testing, Certification, National Certifications, FDA Approved

Coherent with the strategy of consolidating its presence in the global Pharmaceutical domain, Coster has announced that the American FDA has recently awarded the company with a Type III Drug Master File (n. 26960) for its MDI valves: 20DR & 20DPH.

The valves are manufactured in Coster Trento (Italy) facility in a Clean Room Environment, Class 7 at rest.

The newly-awarded DMF joins another filed with the FDA in 2008 for BOVs (Bag-On-Valves) and series 1800 actuators, currently being used in association with anti-mycotic products among other applications.

For more information please send an e-mail to pharma@coster.com.

See also

New player RxPack enters pharmaceutical packaging sector

Coster Group transfers its pharmaceutical aerosol and dispensing business to the newly formed company  RxPack. The new company combines Coster’s products and complementary offerings from Lindal Group to  create a distinctive portfolio of spray packaging solutions for pharmaceutical applications. It is thus ideally  positioned from the start to seize the growth opportunities in this sector. RxPack will be located in Oggiono,  north of Milan in Italy, and is expected to start operations at the end of this year.  

IBSA selects Coster BOV filling line for pharma products

In line with its strategy to increase its presence in the pharmaceutical field, Coster has recently installed a new fully automatic line for filling BOVs (Bag-On-Valves) for Swiss company IBSA. The line is now fully operational at IBSA’s manufacturing site near Milano. The line has a capacity of filling 3,000 cans per hour and has been conceived and designed to produce a variety of IBSA’s successful products, among them an anti-inflammatory topical gel.

  • Company News
  • English
  • Modified 24 Aug 2015
  • Hits 2335